Iron oxide nanoparticles in magnetic drug targeting and ferroptosis-based cancer therapy.
Med Rev (2021)
; 3(5): 444-447, 2023 Oct.
Article
em En
| MEDLINE
| ID: mdl-38283254
ABSTRACT
Iron oxide (IO) nanoparticles (NPs) have gained significant attention in the field of biomedicine, particularly in drug targeting and cancer therapy. Their potential in magnetic drug targeting (MDT) and ferroptosis-based cancer therapy is highly promising. IO NPs serve as an effective drug delivery system (DDS), utilizing external magnetic fields (EMFs) to target cancer cells while minimizing damage to healthy organs. Additionally, IO NPs can generate reactive oxygen species (ROS) and induce ferroptosis, resulting in cytotoxic effects on cancer cells. This article explores how IO NPs can potentially revolutionize cancer research, focusing on their applications in MDT and ferroptosis-based therapy.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Med Rev (2021)
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
China